Metabolomics Technologies for the Identification and Quantification of Dietary Phenolic Compound Metabolites: An Overview

In the search for natural products with properties that may protect against or slow down chronic and degenerative diseases (e.g., cancer, and cardiovascular and neurodegenerative conditions), phenolic compounds (PC) with benefits for human health have been identified. The biological effects of PC in...

সম্পূর্ণ বিবরণ

সংরক্ষণ করুন:
গ্রন্থ-পঞ্জীর বিবরন
প্রধান লেখক: Anallely López-Yerena (Author), Inés Domínguez-López (Author), Anna Vallverdú-Queralt (Author), Maria Pérez (Author), Olga Jáuregui (Author), Elvira Escribano-Ferrer (Author), Rosa M. Lamuela-Raventós (Author)
বিন্যাস: গ্রন্থ
প্রকাশিত: MDPI AG, 2021-05-01T00:00:00Z.
বিষয়গুলি:
অনলাইন ব্যবহার করুন:Connect to this object online.
ট্যাগগুলো: ট্যাগ যুক্ত করুন
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_d0e2a032f87941b08b9024a92367fa03
042 |a dc 
100 1 0 |a Anallely López-Yerena  |e author 
700 1 0 |a Inés Domínguez-López  |e author 
700 1 0 |a Anna Vallverdú-Queralt  |e author 
700 1 0 |a Maria Pérez  |e author 
700 1 0 |a Olga Jáuregui  |e author 
700 1 0 |a Elvira Escribano-Ferrer  |e author 
700 1 0 |a Rosa M. Lamuela-Raventós  |e author 
245 0 0 |a Metabolomics Technologies for the Identification and Quantification of Dietary Phenolic Compound Metabolites: An Overview 
260 |b MDPI AG,   |c 2021-05-01T00:00:00Z. 
500 |a 10.3390/antiox10060846 
500 |a 2076-3921 
520 |a In the search for natural products with properties that may protect against or slow down chronic and degenerative diseases (e.g., cancer, and cardiovascular and neurodegenerative conditions), phenolic compounds (PC) with benefits for human health have been identified. The biological effects of PC in vivo depend on their bioavailability, intestinal absorption, metabolism, and interaction with target tissues. The identification of phenolic compounds metabolites (PCM), in biological samples, after food ingestion rich in PC is a first step to understand the overall effect on human health. However, their wide range of physicochemical properties, levels of abundance, and lack of reference standards, renders its identification and quantification a challenging task for existing analytical platforms. The most frequent approaches to metabolomics analysis combine mass spectrometry and NMR, parallel technologies that provide an overview of the metabolome and high-power compound elucidation. In this scenario, the aim of this review is to summarize the pre-analytical separation processes for plasma and urine samples and the technologies applied in quantitative and qualitative analysis of PCM. Additionally, a comparison of targeted and non-targeted approaches is presented, not available in previous reviews, which may be useful for future metabolomics studies of PCM. 
546 |a EN 
690 |a phenolic compounds 
690 |a metabolites 
690 |a sample treatment 
690 |a NMR 
690 |a LC/MS 
690 |a urine 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Antioxidants, Vol 10, Iss 6, p 846 (2021) 
787 0 |n https://www.mdpi.com/2076-3921/10/6/846 
787 0 |n https://doaj.org/toc/2076-3921 
856 4 1 |u https://doaj.org/article/d0e2a032f87941b08b9024a92367fa03  |z Connect to this object online.